The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

被引:391
作者
Andreux, Penelope A. [1 ]
Blanco-Bose, William [1 ]
Ryu, Dongryeol [1 ,2 ,5 ]
Burdet, Frederic [3 ]
Ibberson, Mark [3 ]
Aebischer, Patrick [4 ]
Auwerx, Johan [2 ]
Singh, Anurag [1 ]
Rinsch, Chris [1 ]
机构
[1] Amazentis SA, EPFL Innovat Pk, Batiment C, Lausanne, Switzerland
[2] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland
[3] SIB Swiss Inst Bioinformat, Vital IT Grp, Batiment Genopode, Lausanne, Switzerland
[4] Ecole Polytech Fed Lausanne, Neurodegenerat Dis Lab, Lausanne, Switzerland
[5] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
关键词
SKELETAL-MUSCLE; ACYLCARNITINES; EXPRESSION; ENERGETICS; AUTOPHAGY;
D O I
10.1038/s42255-019-0073-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Urolithin A (UA) is a natural dietary, microflora-derived metabolite shown to stimulate mitophagy and improve muscle health in old animals and in preclinical models of aging(1). Here, we report the results of a first-in-human clinical trial in which we administered UA, either as a single dose or as multiple doses over a 4-week period, to healthy, sedentary elderly individuals. We show that UA has a favourable safety profile (primary outcome). UA was bioavailable in plasma at all doses tested, and 4 weeks of treatment with UA at doses of 500 mg and 1,000 mg modulated plasma acylcarnitines and skeletal muscle mitochondrial gene expression in elderly individuals (secondary outcomes). These observed effects on mitochondrial biomarkers show that UA induces a molecular signature of improved mitochondrial and cellular health following regular oral consumption in humans.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 34 条
[1]   Mitochondria! function is impaired in the skeletal muscle of pre-frail elderly [J].
Andreux, Penelope A. ;
van Diemen, Marcus P. J. ;
Heezen, Maxime R. ;
Auwerx, Johan ;
Rinsch, Chris ;
Groeneveld, Geert Jan ;
Singh, Anurag .
SCIENTIFIC REPORTS, 2018, 8
[2]  
[Anonymous], 2001, Guidance for industry, bioanalytical method validation
[3]  
[Anonymous], 2007, EMEACHMPSWP2836707
[4]  
Ausländer D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]
[5]   Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers [J].
Chandorkar, Gurudatt ;
Zhan, Qiao ;
Donovan, Julie ;
Rege, Shruta ;
Patino, Hernando .
BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
[6]  
Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]
[7]   Skeletal Muscle Mitochondrial Energetics Are Associated With Maximal Aerobic Capacity and Walking Speed in Older Adults [J].
Coen, Paul M. ;
Jubrias, Sharon A. ;
Distefano, Giovanna ;
Amati, Francesca ;
Mackey, Dawn C. ;
Glynn, Nancy W. ;
Manini, Todd M. ;
Wohlgemuth, Stephanie E. ;
Leeuwenburgh, Christiaan ;
Cummings, Steven R. ;
Newman, Anne B. ;
Ferrucci, Luigi ;
Toledo, Frederico G. S. ;
Shankland, Eric ;
Conley, Kevin E. ;
Goodpaster, Bret H. .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2013, 68 (04) :447-455
[8]  
Committee for Medicinal Products for Human Use (CHMP), 2011, EMEACHMPEWP192217200
[9]   Mitophagy in maintaining skeletal muscle mitochondrial proteostasis and metabolic health with ageing [J].
Drake, Joshua C. ;
Yan, Zhen .
JOURNAL OF PHYSIOLOGY-LONDON, 2017, 595 (20) :6391-6399
[10]   Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease [J].
Fang, Evandro F. ;
Hou, Yujun ;
Palikaras, Konstantinos ;
Adriaanse, Bryan A. ;
Kerr, Jesse S. ;
Yang, Beimeng ;
Lautrup, Sofie ;
Hasan-Olive, Md Mahdi ;
Caponio, Domenica ;
Dan, Xiuli ;
Rocktaschel, Paula ;
Croteau, Deborah L. ;
Akbari, Mansour ;
Greig, Nigel H. ;
Fladby, Tormod ;
Nilsen, Hilde ;
Cader, M. Zameel ;
Mattson, Mark P. ;
Tavernarakis, Nektarios ;
Bohr, Vilhelm A. .
NATURE NEUROSCIENCE, 2019, 22 (03) :401-+